Arkolith/Insider Trading/GTBP/Form 4

Wendel Bruce

DirectorGT Biopharma, Inc. (GTBP) · full profile →Form 4 · filed Oct 7, 2021
Net Buying
Open-Market Buys
$26K
Open-Market Sells
$0
Net Open-Market Flow
$26K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2021Grant(A)348K—$0353K
Dec 22, 2020Buy(P)441$8.73$4K5K
Dec 22, 2020Buy(P)1K$8.87$12K5K
Nov 16, 2020Buy(P)3K$3.14$10K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2021Grant(A)50K—$050K

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-21-010887) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML